BIOMAT Database Logo BIOMAT Database Logo

Synthesis of novel pyrazolo[3,4-b]quinolinyl acetamide analogs, their evaluation for antimicrobial and anticancer activities, validation by molecular modeling and CoMFA analysis. 2017

Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Fluoroorganic Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India; Academy of Scientific and Innovative Research, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500007, India.

A series of novel alkyl amide functionalized 2,3-pyrazole fused quinoline derivatives 5, 6 and 7 have been prepared starting from quinoline-2(1H)one 1 in a series of steps. All the final products were screened for antibacterial activity, the promising lead compound 5r was identified with MIC values ranging between 3.9 and 7.8 μg/mL against different bacterial strains. Compound 5r also showed good antifungal and anti-biofilm activities against the tested panel of various fungal and bacterial strains. Compound 5r when treated on mature biofilms of S. aureus strain MLS16, showed increased levels of intracellular ROS accumulation suggesting its contribution to the bactericidal activity. All the compounds were also screened for anticancer activity against a panel of four human cancer cell lines. Based on these studies, compounds 5c, 5d, 5r and 7f were considered as promising and exhibited significant cytotoxicity with IC50 values of <15 μM. The biological activity data was further validated by molecular modeling and CoMFA studies.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011804 Quinolines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Synthesis, molecular modeling and biological evaluation of new pyrazolo[3,4-b]pyridine analogs as potential antimicrobial, antiquorum-sensing and anticancer agents.
August 2019, Bioorganic chemistry,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
August 2016, Bioorganic chemistry,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Synthesis and antimicrobial activity of novel pyrazolo[3,4-b]quinoline derivatives.
April 2001, Archiv der Pharmazie,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
July 2017, Chemical biology & drug design,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives.
April 2017, Nucleosides, nucleotides & nucleic acids,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile.
January 2016, Biological & pharmaceutical bulletin,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
July 2014, Bioorganic & medicinal chemistry letters,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Anticancer and Anti-Inflammatory Activities of Some New Pyrazolo[3,4-b]pyrazines.
October 2018, Molecules (Basel, Switzerland),
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Synthesis and antiviral evaluation of some novel tricyclic pyrazolo[3,4-b]indole nucleosides.
May 2004, Nucleosides, nucleotides & nucleic acids,
Jitender Dev G, and Y Poornachandra, and K Ratnakar Reddy, and R Naresh Kumar, and N Ravikumar, and D Krishna Swaroop, and P Ranjithreddy, and G Shravan Kumar, and Jagadeesh B Nanubolu, and C Ganesh Kumar, and B Narsaiah
Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
April 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!